Effect of 2-(8-hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl) propionic acid in combination with carboplatin on gastric carcinoma growth in vivo

Table 2 Effect of NM-3 on cell apoptosis of gastric cancer (mean ± SD, %)

Groups	n	AI (TUNEL )	AI (FAScan)
Normal saline	10	2.12 ± 2.19	1.59 ± 0.24
NM-3 (10 mg/kg)	10	6.02 ± 1.63a	3.84 ± 0.68a
NM-3 (20 mg/kg)	10	10.43 ± 3.15ac	8.21 ± 1.01ac
NM-3 (40 mg/kg)	8	22.06 ± 5.68ac	18.26 ± 4.46ac
NM-3 (10 mg/kg) + carplatin	10	8.66 ± 2.35ac	6.96 ± 0.65ac
NM-3 (20 mg/kg) + carplatin	10	12.63 ± 3.75ac	10.65 ± 1.43ac
NM-3 (40 mg/kg) + carplatin	8	24.63 ± 3.67ac	21.66 ± 2.96ac
Carplatin	10	2.47 ± 0.31	1.85 ± 0.34

^aP < 0.05 vs normal saline control group and carboplatin group,

^cP < 0.05 vs NM-3 (10 mg/kg) group.